Possible treatment for pre-malignant bone marrow disorders

Washington D.C. [USA], Dec. 31 : A team of US researchers suggested a new mechanism that controls blood cell function and several possible molecular targets for treating blood cancer. [NK Health] The researchers found that over expression of a protein, called TRAF6 , in blood cells drives the onset of myelodysplasia syndromes – a group of pre-malignant disorders in which bone marrow does not produce enough healthy blood cells.